Elhoff Justin J, Chowdhury Shahryar M, Zyblewski Sinai C, Atz Andrew M, Bradley Scott M, Graham Eric M
1Division of Pediatric Cardiology, Department of Pediatrics, Medical University of South Carolina, Charleston, SC. 2Division of Pediatric Cardiothoracic Surgery, Department of Surgery, Medical University of South Carolina, Charleston, SC.
Pediatr Crit Care Med. 2016 Jan;17(1):30-5. doi: 10.1097/PCC.0000000000000541.
Data supporting the use of perioperative steroids during cardiac surgery are conflicting, and most pediatric studies have been limited by small sample sizes and/or diverse cardiac diagnoses. The objective of this study was to determine if intraoperative steroid administration improved outcomes following the Norwood procedure.
A retrospective analysis was performed on the 549 neonates who underwent a Norwood procedure in the publicly available datasets from the Pediatric Heart Network's Single Ventricle Reconstruction trial. Groups were compared to determine if outcomes differed between intraoperative steroid recipients (n = 498, 91%) and nonrecipients (n = 51, 9%).
Fifteen North American centers.
Infants enrolled in the Single Ventricle Reconstruction trial.
None.
Baseline characteristics and intraoperative variables were similar between groups with the exception of a shorter duration of cross clamp and cardiopulmonary bypass time in the group that received steroids. Subjects who did not receive intraoperative steroids had improved hospital survival (94% vs 83%, p = 0.03) but longer ICU stays (16 d; interquartile range, 12-33 vs 14 d; interquartile range, 9-28; p = 0.04) and hospital stays (29 d; interquartile range, 21-50 vs 23 d; interquartile range, 15-40; p = 0.01) than steroid recipients. In multivariate analysis, lengths of stay associations were no longer significant, but hospital survival trended toward favoring the nonsteroid group with an odds ratio of 3.52 (95% CI, 0.98-12.64; p = 0.054).
In the large multicentered Single Ventricle Reconstruction trial, there was widespread use of intraoperative steroids. Intraoperative steroid administration was not associated with an improvement in outcomes and may be associated with a reduction in hospital survival in neonates undergoing the Norwood procedure. This study highlights the need for a randomized control trial.
支持在心脏手术期间使用围手术期类固醇的数据相互矛盾,并且大多数儿科研究受到样本量小和/或心脏诊断多样的限制。本研究的目的是确定术中给予类固醇是否能改善诺伍德手术(Norwood procedure)后的结局。
对在儿科心脏网络单心室重建试验公开数据集中接受诺伍德手术的549例新生儿进行回顾性分析。比较各组以确定术中接受类固醇治疗者(n = 498,91%)和未接受者(n = 51,9%)的结局是否存在差异。
北美15个中心。
纳入单心室重建试验的婴儿。
无。
除接受类固醇治疗组的主动脉阻断时间和体外循环时间较短外,两组间的基线特征和术中变量相似。未接受术中类固醇治疗的受试者住院生存率更高(94%对83%,p = 0.03),但与接受类固醇治疗者相比,重症监护病房(ICU)住院时间更长(16天;四分位间距,12 - 33天对14天;四分位间距,9 - 28天;p = 0.04),住院时间也更长(29天;四分位间距,21 - 50天对23天;四分位间距,15 - 40天;p = 0.01)。在多变量分析中,住院时间的相关性不再显著,但住院生存率倾向于非类固醇组,优势比为3.52(95%可信区间,0.98 - 12.64;p = 0.054)。
在大型多中心单心室重建试验中,术中类固醇的使用很普遍。术中给予类固醇与结局改善无关,且可能与接受诺伍德手术的新生儿住院生存率降低有关。本研究强调了进行随机对照试验的必要性。